Cathie Wood Biomarin Pharmaceutical Inc Transaction History

Ark Investment Management LLC

  • $11 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022
SELL
$71.48 - $86.85 $7,576 - $9,206
-106 Reduced 4.54%
2,228 $167,000
Q1 2022

Apr 19, 2022
BUY
$74.28 - $92.69 $173,369 - $216,338
2,334 New
2,334 $180,000
Q1 2017

May 15, 2017
SELL
N/A
-960 Closed
0 $0
Q4 2016

Feb 13, 2017
BUY
N/A
960
960 $80,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email